Tom C. Thomas - 23 May 2024 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role
General Counsel and Chief Legal Officer
Signature
By: /s/ Tom C. Thomas
Issuer symbol
VINC
Transactions as of
23 May 2024
Net transactions value
$0
Form type
4
Filing time
29 May 2024, 20:55:31 UTC
Previous filing
08 Mar 2024
Next filing
14 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VINC Stock Option (right to buy) Award $0 +31,250 +33% $0.000000 125,000 23 May 2024 Common Stock 31,250 $7.38 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option grant was approved on March 7, 2024, subject to stockholder approval of an amendment to the Vincerx Pharma, Inc. 2020 Stock Incentive Plan. The stockholders approved the amendment on May 23, 2024.
F2 One-third (1/3) vests on March 7, 2025, with the remainder vesting in twenty-four equal monthly installments thereafter.

Remarks:

General Counsel and Chief Legal Officer